THBI Statement on NIH Guidance to Reduce Funding for Medical and Life Science Research
AUSTIN, TX - February 12, 2025 –The Texas Healthcare and Bioscience Institute (THBI), the statewide organization representing the life science industry in Texas, expresses deep concern over the recent guidance released by the National Institutes of Health (NIH) to limit funding for medical and life science research at Institutions of Higher Education. This decision will have far reaching and detrimental consequences for Texas’ innovation economy and workforce, as well as its ability to remain a cutting-edge leader in research and development.
Texas Healthcare & Bioscience Institute Releases New Industry Report: “Texas Life Sciences: Building the Innovations of Tomorrow”
Texas Healthcare & Bioscience Institute Releases New Industry Report: “Texas Life Sciences: Building the Innovations of Tomorrow”
AUSTIN, TX – March 18, 2024 – THBI today released a new report highlighting the state’s world-class life science and biotech industry. The report, “Texas Life Sciences: Building the Innovations of Tomorrow,” outlines Texas’ investments in the space, highly skilled workforce, and the extensive network of companies, making it the ideal incubator for building the innovations of tomorrow for all Texans.
Texas Healthcare & Bioscience Institute Hosting the Texas Life Sciences Summit
THBI Welcomes U.S. Advanced Research Projects Agency (ARPA-H) to Texas
THBI Welcomes U.S. Advanced Research Projects Agency (ARPA-H) to Texas
AUSTIN, TX – September 27, 2023 –The Texas Healthcare & Bioscience Institute (THBI) is thrilled to welcome the Advanced Research Projects Agency for Health (ARPA-H) to the Lone Star State. This new U.S. Department of Health and Human Services (HHS) agency is a nationwide health innovation network that will support transformative biomedical and health breakthroughs.
THBI Announces Luminary Award Recipients
New Report Examines the Bioscience Industry’s Economic Performance Nationally and in Texas
New Report Examines the Bioscience Industry’s Economic Performance Nationally and in Texas
AUSTIN, TX – November 1, 2022 –The Texas Healthcare & Bioscience Institute (THBI), the trade association for the life science, bioscience and biotech industry in Texas, is thrilled to share the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations’ (CSBA) new data on the bioscience industry in the United States and specifically in Texas.
THBI Hosts Annual Policy Summit and Awards Dinner with Impressive Speaker Line Up
AUSTIN, TX – October 7, 2022 - The Texas Healthcare and Bioscience Institute (THBI) will host its annual Fall Policy Summit and Luminary Awards Dinner Thursday, October 20 at the Stephen F. Austin Hotel in downtown Austin.
THBI Names New Director of Policy
AUSTIN, TX - September 26, 2022 – The Texas Healthcare and Bioscience Institute (THBI) is pleased to welcome Danielle Lobsinger Bush as the new Director of Policy. Lobsinger Bush, as Director of Policy, will play a key role in advocating on issues important to the life science and bioscience industry in Texas at both the state and federal level.
MADE in America Act is Critical for the Pharmaceutical Industry
DALLAS, TX - September 24, 2022 –The last couple of years are ripe with many lessons. From education to healthcare access to supply chains, America has had to revisit and revamp the way we work, learn and do business. We’ve also been confronted with the challenges of our global interdependence.
U.S. Medical Progress is in Jeopardy
DALLAS, TX - April 16, 2022 - Every day patients from around the country arrive in North Texas desperate for help, anxious for answers and hopeful for a cure. They come here for world-class medical treatment and to participate in one of the many clinical trials underway for a range of diseases from Alzheimer’s to cancer.
Texas Can Take Action to Lower Prescription Drug Costs
LONGVIEW, TX - April 9, 2022 – Picture this next time you visit a restaurant. The kitchen makes the food and a waiter delivers the dish to your table, but with an added complexity: the waiter negotiated the cost of your enchilada plate with the kitchen, and you’ll learn the price when you receive the check.
THBI Names New Director of Operations and Economic Development
AUSTIN, TX - March 29, 2022 – The Texas Healthcare and Bioscience Institute (THBI) is welcoming Miranda Goodsheller as its new Director of Operations and Economic Development. Goodsheller will be the organization’s first team member to focus not only on operational success but also on enhancing THBI’s economic development initiatives that support the growing Texas life science industry.
Study: Middlemen Drive the Cost of Brand Name Medicines
AUSTIN, TX, January 27, 2022 – An updated study from the Berkeley Research Group (BRG) shows more than half (50.5 percent) of total spending on brand-name prescription drugs goes to middlemen like pharmacy benefit managers (PBMs) and other stakeholders in the drug supply chain – not to drug manufacturers.
THBI Names New President and CEO
AUSTIN, TX - December 7, 2021 – The Texas Healthcare and Bioscience Institute (THBI) is welcoming Victoria Ford as its new President and CEO. Ford will be the organization’s second head executive following the retirement of Thomas Kowalski, who served as THBI’s President and CEO since its inception 25 years ago. Kowalski announced his retirement in August.